13. Department of Safety Research on
Blood and Biological Products

Hamaguchi I. Establishment of a new quality control andvaccine safety test for influenza vaccines and adjuvants
using gene expression profiling. PLoS One. in press

1)

9)

Kusunoki H, Tanaka T, Kohno T, Wakamatsu K,Okuma K, Fukagawa K, Tateyama S, Kohma T,

Hamaguchi I: Structural characterization of the BH3-likeMochida K, Hiyoshi M, Takahama Y, Hamaguchi Y,

motif of hepatitis B virus X protein. Biochem Biophys Res

Hirose K, Buonocore L, Rose JK, Mizuochi T, Hamaguchi

Commun, 450: 741-745, 2014

I. Development of an infectious surrogate hepatitis C virus

2)

11315

Tanio M, Kusunoki H, KohnoT: H, C and N

based on a recombinant vesicular stomatitis virus

backbone resonance assignments of the monomeric humanexpressing hepatitis C virus envelope glycoproteins andM-ficolin fibrinogen-like domain secreted by Brevibacillus

green fluorescent protein. Jpn J Infect Dis. in press

choshinensis. Biomol NMR Assign, 8: 207-211, 2014

10)

3)

M, Kuramitsu

Mizukami T, Momose H, Kuramitsu M, Takizawa K,Hiyoshi M, Okuma K, Tateyama S, Takizawa K, Saito
M, Araki K, Morishita

K, Okada S,Araki K, Furuhata K, Ishii KJ, Hamaguchi I, Yamaguchi K.

Yamamoto N, Biragyn A, Yamaguchi K, Hamaguchi I:

System vaccinology for the evaluation of influenza vaccine

Furin-dependent CCL17-fused recombinant toxin controls

safety by multiplex gene detection of novel biomarkers in a

HTLV-1 infection by targeting and eliminating infectedpreclinical study and batch release test. PLoS One. 9:

CCR4-expressing cells in vitro and in vivo. Retrovirology,e101835. 2014

in press4)

11)

Epstein J, Ganz PR, Seitz R, Jutzi M, Schaerer C,Kuramitsu M, Okuma K, Yamochi T, Sato T, Sasaki

Michaud G, Agbanyo F, Smith G, Prosser I, Heiden M,D, Hasegawa H, Umeki K, Kubota R, Sobata R,

Saint-Marie I, Oualikene-Gonin W, Hamaguchi I, Yasuda

Matsumoto C, Kaneko N, Naruse I, Yamagishi M,

N: A shared regulatory perspective on deferral from blood

Nakashima M, Momose H, Araki K, Mizukami T,donation of men who have sex with men (MSM). Vox

Mizusawa S, Okada Y, Ochiai M, Utsunomiya A, Koh K-R,Sang, 107(4):416-9, 2014.

Ogata M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y,5)

Yamano Y, Satake M, Okayama A, Mochizuki M, Izumo S,

Iho S, Maeyama J, Suzuki F: CpG oligodeoxy-nucleotides

asmucosal

adjuvants.

HumVaccin

Saito S, Itabashi K, Kamihira S, Yamaguchi K, Watanabe T,Immunother. 11: 755-60 2015.

Hamaguchi I: Standardization of quantitative PCR for6)

human T-cell leukemia virus type 1 in Japan: AKuramitsu M, Okuma K, Yamagishi M, Yamochi T,Firouzi S, Momose H, Mizukami T, Takizawa K, Araki K,Sugamura K, Yamaguchi K, Watanabe T, Hamaguchi I.
2015. Identification of TL-Om1, an Adult T-Cell Leukemia(ATL) Cell Line, as Reference Material for Quantitative
PCR for Human T-Lymphotropic Virus 1. J Clin Microbiol.
53:587-596.
7)

Wang R, Yoshida K, Toki T, Sawada T, Uechi T,Okuno Y, Sato-Otsubo A, Kudo K, Kamimaki I, KanezakiR, Shiraishi Y, Chiba K, Tanaka H, Terui K, Sato T, Iribe Y,Ohga S, Kuramitsu M, Hamaguchi I, Ohara A, Hara J, GoiK, Matsubara K, Koike K, Ishiguro A, Okamoto Y,Watanabe K, Kanno H, Kojima S, Miyano S, Kenmochi N,Ogawa S, Ito E: Loss of function mutations in RPL27 andRPS27

identified

bywhole-exome

sequencing

inDiamond-Blackfan anaemia. Br J Haematol 168:854-864,20158)

Momose H, Mizukami T, Kuramitsu M, Takizawa K,Masumi A, Araki K, Furuhata K, Yamaguchi K,

collaborative study. J. Clin. Microbiol. In press